Edition:
United Kingdom

Sunesis Pharmaceuticals Inc (SNSS.OQ)

SNSS.OQ on NASDAQ Stock Exchange Capital Market

6.64USD
23 Feb 2018
Change (% chg)

$-0.15 (-2.21%)
Prev Close
$6.79
Open
$6.77
Day's High
$6.77
Day's Low
$6.34
Volume
52,840
Avg. Vol
39,865
52-wk High
$7.25
52-wk Low
$1.84

Select another date:

Mon, Dec 4 2017

BRIEF-Sunesis Pharmaceuticals Inc - Daniel Swisher Resigns As CEO Effective End Of 2017

* SUNESIS PHARMACEUTICALS INC - DANIEL SWISHER RESIGNS AS CEO EFFECTIVE END OF 2017

BRIEF-Sunesis Pharmaceuticals Appoints William Quinn As CFO

* SUNESIS PHARMACEUTICALS APPOINTS WILLIAM QUINN AS CHIEF FINANCIAL OFFICER AND SENIOR VICE PRESIDENT, FINANCE AND CORPORATE DEVELOPMENT

BRIEF-RA Capital Management reports 10.4 pct passive stake in Sunesis Pharmaceuticals as of Oct 25

* RA Capital Management reports 10.4 percent passive stake in Sunesis Pharmaceuticals as of October 25 – SEC Filing‍​ Source text: [http://bit.ly/2yZzSQ5] Further company coverage:

BRIEF-Sunesis Pharmaceuticals Inc Q3 loss per share ‍$0.43​

* Sunesis Pharmaceuticals reports third quarter 2017 financial results and recent highlights

BRIEF-Sunesis announces pricing of $20 million offering of securities

* Sunesis announces pricing of $20 million offering of securities

BRIEF-Sunesis Pharmaceuticals announces proposed public offering of common stock, preferred stock and warrants

* Sunesis announces proposed public offering of common stock, preferred stock and warrants

Select another date: